Another possibility is that GCH1 mutation carriers who do not develop symptoms of DOPA-responsive dystonia in childhood may have compensatory mechanisms that allow for normal nigrostriatal dopaminergic transmission. The gene discussed is GCH1; the disease is Dystonia.